NPS-2143 is a selective Ca2+-sensing receptor antagonist, shown to block increases in cytoplasmic Ca2+ concentrations elicited by human Ca2+ receptors expressed in HEK293 cells with an IC50 of 43 nM.
More Information Supplier PageRetapamulin is an antibacterial agent, specifically a protein synthesis inhibitor
More Information Supplier PageRetapamulin is an antibacterial agent, specifically a protein synthesis inhibitor
More Information Supplier PageRetapamulin is an antibacterial agent, specifically a protein synthesis inhibitor
More Information Supplier PageRetapamulin is an antibacterial agent, specifically a protein synthesis inhibitor
More Information Supplier PageRetapamulin is an antibacterial agent, specifically a protein synthesis inhibitor
More Information Supplier PageTOK-001 (Galeterone) is both an androgen receptor antagonist and CYP17A1 inhibitor.
More Information Supplier PageLY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information Supplier PageLY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information Supplier PageINCB28060, a novel inhibitor of c-MET kinase. INCB28060 exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.
More Information Supplier Page
